Recruiting NA INTERVENTIONAL 2-arm
NCT07279623
Intra-Nasal Mechanical Stimulation (INMEST) as a Potential Preventative Treatment for Migraine (A-MI-01)
Intra-Nasal Mechanical Stimulation (INMEST) as a Potential Preventative Treatment for Migraine - A Prospective, Randomized, Open Label, Delayed-Start Study to Evaluate the Safety and Performance of the Walther System
Sponsor: Abilion Medical Systems AB
Conditions
Migraine
Interventions
INMEST-treatment
Updated 1 time since 2026 Last updated: Dec 10, 2025 Started: Oct 21, 2025 Primary completion: Sep 30, 2026 Completion: Sep 30, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This NA trial investigates Migraine and is currently actively recruiting participants. Abilion Medical Systems AB leads this study, which shows 1 recorded version since 2025 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
1 version recorded Recruiting — NA
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Abilion Medical Systems AB
- Aurevia
- Insamlingsstiftelsen för främjande av forskning avseende INMEST
Data source: Abilion Medical Systems AB
For direct contact, visit the study record on ClinicalTrials.gov .